103 related articles for article (PubMed ID: 33463281)
21. The effect of bone morphogenic protein-2-coated tri-calcium phosphate/hydroxyapatite on new bone formation in a rat model of femoral distraction osteogenesis.
Yang JH; Kim HJ; Kim SE; Yun YP; Bae JH; Kim SJ; Choi KH; Song HR
Cytotherapy; 2012 Mar; 14(3):315-26. PubMed ID: 22122301
[TBL] [Abstract][Full Text] [Related]
22. Bone morphogenetic proteins - 7 and - 2 in the treatment of delayed osseous union secondary to bacterial osteitis in a rat model.
Helbig L; Omlor GW; Ivanova A; Guehring T; Sonntag R; Kretzer JP; Minkwitz S; Wildemann B; Schmidmaier G
BMC Musculoskelet Disord; 2018 Jul; 19(1):261. PubMed ID: 30049273
[TBL] [Abstract][Full Text] [Related]
23.
Horstmann PF; Raina DB; Isaksson H; Hettwer W; Lidgren L; Petersen MM; Tägil M
Tissue Eng Part A; 2017 Dec; 23(23-24):1403-1412. PubMed ID: 28537526
[TBL] [Abstract][Full Text] [Related]
24. Long-Term Response to a Bioactive Biphasic Biomaterial in the Femoral Neck of Osteoporotic Rats.
Raina DB; Širka A; Qayoom I; Teotia AK; Liu Y; Tarasevicius S; Tanner KE; Isaksson H; Kumar A; Tägil M; Lidgren L
Tissue Eng Part A; 2020 Oct; 26(19-20):1042-1051. PubMed ID: 32242474
[TBL] [Abstract][Full Text] [Related]
25. Repair of rat calvarial bone defects by controlled release of rhBMP-2 from an injectable bone regeneration composite.
Tan R; She Z; Wang M; Yu X; Jin H; Feng Q
J Tissue Eng Regen Med; 2012 Aug; 6(8):614-21. PubMed ID: 21916016
[TBL] [Abstract][Full Text] [Related]
26. Nanohydroxyapatite Based Ceramic Carrier Promotes Bone Formation in a Femoral Neck Canal Defect in Osteoporotic Rats.
Qayoom I; Teotia AK; Kumar A
Biomacromolecules; 2020 Feb; 21(2):328-337. PubMed ID: 31637919
[TBL] [Abstract][Full Text] [Related]
27. Nano-Hydroxyapatite Bone Substitute Functionalized with Bone Active Molecules for Enhanced Cranial Bone Regeneration.
Teotia AK; Raina DB; Singh C; Sinha N; Isaksson H; Tägil M; Lidgren L; Kumar A
ACS Appl Mater Interfaces; 2017 Mar; 9(8):6816-6828. PubMed ID: 28171719
[TBL] [Abstract][Full Text] [Related]
28. A single percutaneous injection of recombinant human bone morphogenetic protein-2 accelerates fracture repair.
Einhorn TA; Majeska RJ; Mohaideen A; Kagel EM; Bouxsein ML; Turek TJ; Wozney JM
J Bone Joint Surg Am; 2003 Aug; 85(8):1425-35. PubMed ID: 12925621
[TBL] [Abstract][Full Text] [Related]
29. Ability of recombinant human bone morphogenetic protein 2 to enhance bone healing in the presence of tobramycin: evaluation in a rat segmental defect model.
Glatt V; Kwong FN; Park K; Parry N; Griffin D; Vrahas M; Evans CH; Harris M
J Orthop Trauma; 2009; 23(10):693-701. PubMed ID: 19858977
[TBL] [Abstract][Full Text] [Related]
30. Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling.
McDonald MM; Dulai S; Godfrey C; Amanat N; Sztynda T; Little DG
Bone; 2008 Oct; 43(4):653-62. PubMed ID: 18582604
[TBL] [Abstract][Full Text] [Related]
31. Combination therapy with low-dose teriparatide and zoledronate contributes to fracture healing on rat femoral fracture model.
Tsubouchi Y; Ikeda S; Kataoka M; Tsumura H
J Orthop Surg Res; 2018 Oct; 13(1):267. PubMed ID: 30359257
[TBL] [Abstract][Full Text] [Related]
32. Combination therapy with BMP-2 and a systemic RANKL inhibitor enhances bone healing in a mouse critical-sized femoral defect.
Bougioukli S; Jain A; Sugiyama O; Tinsley BA; Tang AH; Tan MH; Adams DJ; Kostenuik PJ; Lieberman JR
Bone; 2016 Mar; 84():93-103. PubMed ID: 26723577
[TBL] [Abstract][Full Text] [Related]
33. Early inhibitory effects of zoledronic acid in tooth extraction sockets in dogs are negated by recombinant human bone morphogenetic protein.
Gerard DA; Carlson ER; Gotcher JE; Pickett DO
J Oral Maxillofac Surg; 2014 Jan; 72(1):61-6. PubMed ID: 23891015
[TBL] [Abstract][Full Text] [Related]
34.
Cho TH; Kim IS; Lee B; Park SN; Ko JH; Hwang SJ
Tissue Eng Part A; 2017 Dec; 23(23-24):1343-1360. PubMed ID: 28457207
[TBL] [Abstract][Full Text] [Related]
35. BMP-2 delivered via sucrose acetate isobutyrate (SAIB) improves bone repair in a rat open fracture model.
Cheng TL; Schindeler A; Little DG
J Orthop Res; 2016 Jul; 34(7):1168-76. PubMed ID: 26679381
[TBL] [Abstract][Full Text] [Related]
36. Manipulation of the anabolic and catabolic responses with OP-1 and zoledronic acid in a rat critical defect model.
Little DG; McDonald M; Bransford R; Godfrey CB; Amanat N
J Bone Miner Res; 2005 Nov; 20(11):2044-52. PubMed ID: 16234978
[TBL] [Abstract][Full Text] [Related]
37. Modulation of anabolic and catabolic responses via a porous polymer scaffold manufactured using thermally induced phase separation.
Yu NY; Schindeler A; Peacock L; Mikulec K; Fitzpatrick J; Ruys AJ; Cooper-White JJ; Little DG
Eur Cell Mater; 2013 Feb; 25():190-203. PubMed ID: 23444237
[TBL] [Abstract][Full Text] [Related]
38. Effect of combined treatment with zoledronic acid and parathyroid hormone on mouse bone callus structure and composition.
Casanova M; Herelle J; Thomas M; Softley R; Schindeler A; Little D; Schneider P; Müller R
Bone; 2016 Nov; 92():70-78. PubMed ID: 27542660
[TBL] [Abstract][Full Text] [Related]
39. Spatial control of bone formation using a porous polymer scaffold co-delivering anabolic rhBMP-2 and anti-resorptive agents.
Yu NY; Gdalevitch M; Murphy CM; Mikulec K; Peacock L; Fitzpatrick J; Cantrill LC; Ruys AJ; Cooper-White JJ; Little DG; Schindeler A
Eur Cell Mater; 2014 Jan; 27():98-109; discussion 109-111. PubMed ID: 24488823
[TBL] [Abstract][Full Text] [Related]
40. Effect of rhBMP-2 sustained-release nanocapsules on the ectopic osteogenesis process in Sprague-Dawley rats.
Lai RF; Li ZJ; Zhou ZY; Feng ZQ; Zhao QT
Asian Pac J Trop Med; 2013 Nov; 6(11):884-8. PubMed ID: 24083584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
